34 results on '"Gollrad, Johannes"'
Search Results
2. Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients
3. Side effects of proton beam therapy of choroidal melanoma in dependence of the dose to the optic disc and the irradiated length of the optic nerve
4. Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
5. RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial
6. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy: Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression
7. Depression and anxiety in patients with uveal melanoma undergoing curative proton treatment—A prospective study
8. Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome
9. News from the OOG Meeting in April 2023 in Berlin.
10. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes
11. Tunneled hemodialysis catheter insertion: Above, within, or below the right atrium—Where is the tip?
12. Proton therapy of iris melanoma with 50 CGE: Influence of target volume on clinical outcome
13. Performance of OncoE6 cervical test with collection methods enabling self-sampling
14. Technical note: Impact of beam properties for uveal melanoma proton therapy—An in silico planning study
15. Fear of Prognosis? How Anxiety, Coping, and Expected Burden Impact the Decision to Have Cytogenetic Assessment in Uveal Melanoma Patients
16. Impact of adjuvant ocular interventions on the quality of life of patients with uveal melanoma after proton beam therapy
17. Additional file 19 of Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
18. Additional file 7 of Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
19. Additional file 4 of Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
20. Additional file 8 of Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
21. Additional file 20 of Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
22. Additional file 9 of Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
23. Additional file 5 of Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
24. Additional file 6 of Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
25. Additional file 3 of Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma
26. FLASH proton irradiation setup with a modulator wheel for a single mouse eye
27. Impact of Adjuvant Ocular Interventions on the Quality of Life of Patients with Uveal Melanoma after Proton Beam Therapy.
28. Towards FLASH Proton Irradiation at HZB
29. DURTRERAD: A phase II open-label study evaluating feasibility and efficacy of durvalumab (D) and durvalumab and tremelimumab (DT) in combination with radiotherapy (RT) in non-resectable locally advanced HPV-negative HNSCC—Results of the preplanned feasibility interim analysis.
30. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy
31. Salvage-Radiotherapie bei Prostatakarzinompatienten mit biochemischem Rezidiv nach radikaler Prostatektomie : Verlängerung der Verdopplungszeit des prostataspezifischen Antigens bei Patienten mit anschließendem biochemischem Progress.
32. Protonentherapie des Irismelanoms mit 50 CGE : Einfluss des Zielvolumens auf das klinische Ergebnis.
33. Outcome of Elderly Patients with Meningioma after Image-Guided Stereotactic Radiotherapy: A Study of 100 Cases
34. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.